Science & Enterprise subscription

Follow us on Twitter

  • A biotechnology company using protein dynamics to develop precision cancer therapies is acquiring a drug discovery… https://t.co/AzEb3ERy5f
    about 6 hours ago
  • New post on Science and Enterprise: AI Drug Discovery Company Acquired in $270M Deal https://t.co/GhPSuGMAHO #Science #Business
    about 6 hours ago
  • Drug maker Eli Lilly and Co. asked the Food and Drug Administration to revoke its authorization for bamlanivimab al… https://t.co/xtrdcKMDgx
    about 12 hours ago
  • New post on Science and Enterprise: Lilly Asks FDA to Revoke Covid-19 Therapy Clearance https://t.co/FNA6Qlklwy #Science #Business
    about 12 hours ago
  • Vaccine developer Novavax is taking part in a clinical trial testing effects of different Covid-19 vaccines in firs… https://t.co/AMeVYLYh30
    about 1 day ago

Please share Science & Enterprise

Space Company Launches European Comm. Satellite

Artist view of Eutelsat Ka-Sat (Astrium)

Artist view of Eutelsat Ka-Sat (Astrium)

International Launch Services (ILS), a commercial space services company, launched the Ka-Sat satellite (pictured left) to orbit for Eutelsat Communications of France on an ILS Proton rocket from its facility at Baikonur Cosmodrome in Kazahkstan. After a nine-hour mission, the KA-SAT was released into a geostationary transfer orbit.

The Proton Breeze M vehicle used in this mission is built by Khrunichev Space Center of Moscow, ILS’s majority owner. ILS says the Proton launch vehicle has a record of 363 missions since its maiden flight in 1965.

The 6,150 kg KA-SAT satellite was built on the Eurostar E3000 platform by Astrium, the space systems subsidiary of EADS, and has a 15 year life expectancy. The satellite is expected to provide high-speed broadband Internet connectivity to customers in Europe and the Mediterranean Basin.

*     *     *

1 comment to Space Company Launches European Comm. Satellite